Physician

David P Bender, MD

According to 2025 Medicare claims, David Bender, MD (NPI: 1487641247) practices gynecologist/oncologist in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Rock Island, IL. This provider's primary affiliated billing organization is STATE UNIVERSITY OF IOWA (NPI: 1477554814; TIN: 426004813) and primary practice location at 52242-1009. Bender is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Bender's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 162 traditional Medicare patients, billed 410 HCPCS/CPT codes, and received $59,238 in Medicare payments. The top billing code was 58571 (Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less). Part D data shows 88 prescription claims across 33 beneficiaries totaling $73,507 in drug costs, led by Neomycin Sulfate (Neomycin Sulfate). DME data shows 42 claims. Open Payments data shows 4 records totaling $19,047. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $107,923 to $59,238. In contrast, Part D prescription costs have risen steadily, from $447 to $73,507. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $3,080 and ending at $747.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	204	497	$107,923
2016	203	520	$101,359
2017	239	619	$108,349
2018	259	625	$109,384
2019	187	509	$90,470
2020	194	521	$99,260
2021	218	574	$107,096
2022	207	535	$93,352
2023	188	515	$84,093
2024	162	410	$59,238

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	19	28	$447
2016	26	62	$1,821
2017	28	89	$15,444
2018	24	61	$2,102
2019	21	51	$6,449
2020	23	47	$3,739
2021	19	32	$3,793
2022	14	22	$2,501
2023	19	56	$30,359
2024	33	88	$73,507

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	76	$4,449
2016	N/R	36	$1,569
2017	N/R	84	$5,435
2018	N/R	67	$8,182
2019	N/R	105	$9,360
2020	N/R	164	$13,910
2021	N/R	61	$4,184
2022	N/R	43	$3,454
2023	N/R	132	$9,891
2024	N/R	42	$8,059

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
58571	Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less	26	26	$644
38570	Biopsy and removal of lymph nodes of abdominal cavity using an endoscope	21	21	$194
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	47	47	$125
38900	Imaging of lymph nodes during surgery	21	21	$98
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	101	175	$48

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Neomycin Sulfate	Neomycin Sulfate	12	12	$66
Metronidazole	Metronidazole	13	19	$35

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A5057	Ostomy pouch, drainable, with extended wear barrier attached, with built in convexity, with filter, (1 piece), each	N	N/R	13	$4,143
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	N/R	18	$2,615
A4362	Skin barrier; solid, 4 x 4 or equivalent; each	N	N/R	11	$1,301

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$19,047	GlaxoSmithKline, LLC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David P. Bender, MD?

Tedicare shows public-source Medicare data for David P. Bender, MD (NPI 1487641247), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David P. Bender, MD have ACO affiliation data?

David P. Bender, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to David P. Bender, MD?

David P. Bender, MD is linked to STATE UNIVERSITY OF IOWA (billing NPI 1477554814) in the available physician profile data.

Does David P. Bender, MD have Open Payments data?

David P. Bender, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.